&Partners’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RXRX
&Partners's RXRX Position: Q3 2026 in Review
&Partners opened a new position in Recursion Pharmaceuticals (RXRX) in Q3 2026: 10,616 shares worth $43.8K. The stake represents ﹤0.01% of the portfolio and ranks #2635 among its holdings.
352 funds tracked by Wall St. Rank hold RXRX as of Q3 2026.
- &Partners held 10,616 shares of Recursion Pharmaceuticals worth $43.8K as of Q3 2026.
- Recursion Pharmaceuticals was a new &Partners position in Q3 2026.
- Recursion Pharmaceuticals made up ﹤0.01% of &Partners's portfolio in Q3 2026, its #2635 holding.
- 352 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q3 2026.
Based on &Partners's 13F filing for Q3 2026, filed 16 Nov 2026.